Early detection of Parkinson's disease (PD) is important which can enable early initiation of therapeutic interventions and management strategies. However, methods for early detection still remain an unmet clinical need in PD. In this study, we use the Patient Questionnaire (PQ) portion from the widely used Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) to develop prediction models that can classify early PD from healthy normal using machine learning techniques that are becoming popular in biomedicine: logistic regression, random forests, boosted trees and support vector machine (SVM). We carried out both subjectwise and record-wise validation for evaluating the machine learning techniques. We observe that these techniques perform with high accuracy and high area under the ROC curve (both >95%) in classifying early PD and healthy normal. The logistic model demonstrated statistically significant fit to the data indicating its usefulness as a predictive model. It is inferred that these prediction models have the potential to aid clinicians in the diagnostic process by joining the items of a questionnaire through machine learning.
Introduction
Parkinson's disease (PD) is a neurodegenerative disorder affecting millions of elderly people, significantly affecting their quality of lives [1] . PD is a complex disorder characterized by several motor and non-motor symptoms that worsen over time. In advanced stages of PD, clinical diagnosis is clear-cut. However, in the early stages, when the symptoms are often incomplete or subtle, the diagnosis becomes difficult and at times, the subject may remain undiagnosed. For instance, a large-scale epidemiological study on a European cohort showed that a significant proportion of previously undetected subjects, were diagnosed with PD, after screening them with a symptom questionnaire followed by physical examination and clinical intervention [2] . Tremor, the most common symptom in PD, may never manifest in some patients and the patient may show other relevant symptoms such as bradykinesia (slower and smaller handwriting, decreased arm swing and leg stride when walking, decreased facial expression, and decreased amplitude of voice) to begin with [1] . The difficulty in early detection of PD is a strong motivation for computer-based assessment tools/decision support tools/test instruments that can aid in the early diagnosis of PD. Timely detection, preferably at a stage earlier than currently possible, and subsequent intervention could be hugely beneficial in a way that the patient could have access to disease modifying therapy to slow down the course of PD progression.
Machine learning provides seemingly immense opportunities to computer-aided classification and diagnosis that could reduce inevitable fallibilities and inherent diagnostic variabilities in healthcare, provide guidance (especially in a setting when expert physicians are not available), and speed up decision making. These models can aid in the early detection of PD and also for identifying subjects for clinical trials. Researchers have used a variety of data for solving the PD detection problem via machine learning techniques. [3] [4] [5] [6] [7] used speech data, [8] studied gait patterns, [9] carried out analysis on force tracking data, [10] [11] [12] performed analysis on single photon emission computed tomography (SPECT) scan data, and [13] used smell identification data to distinguish PD from healthy normal. [14] carried out assessment of PD state based on many weeks of movement data collected from sensors from 34 subjects who were in mild to severe PD. [15] describes about the collaboration between Michael J. Fox Foundation for PD Research and Intel Corporation, to develop a mobile application and an Internet of Things (IoT) platform to support large-scale studies of objective, continuously sampled sensory data from people with PD. [16] in their study, proposes an approach to evaluate the feasibility and compliance of using multiple wearable sensors to collect clinically relevant data, and to address the usability of these data for answering clinical research questions. [17] is a continuation of their previous study [16] where they complete their data collection process and show that it is feasible to deploy a technology platform consisting of consumer-grade wearable and mobile devices to capture large amounts of sensor data from many participants from a large and geographically diverse PD population. [18] presents an approach to analyze smartwatch data from 19 PD subjects and shows high performance in terms of detecting symptoms of tremor, bradykinesia, and dyskinesia. [19] showed that dual-wrist sensor fusion may enable robust gait quantification (aiding in capturing timing-based, gait abnormalities) in free-living environments. [20] provides a review which discusses promising wearable technology, addresses which parameters should be prioritized in such assessment strategies, and reports about studies that have already investigated daily life issues in PD using this new technology. [21] used imaging, genetics, clinical and demographic data to develop prediction models for PD. [22] developed predictions models for PD using genetic, non-motor and demographic data. [23] used motor, non-motor and imaging data from to develop prediction models for PD. [24] developed multi-task learning model for the prediction of PD progression, measured using baseline measurements of biologic specimen, clinical assessments and brain imaging. [25] explored the non-motor symptoms (NMS) and quality of life (QOL) in tremor dominant (TD) vs. postural instability gait disorder (PIGD) PD patients, and observed that PIGD phenotype had a higher prevalence of NMS and worse QOL than TD phenotype. These studies had one or more of the following shortcomings: they used only the partial aspects of PD (for example, using only motor aspects like speech or movement or non-motor aspects like the difficulty in olfaction) and did not make use of broad spectrum of symptoms in PD (both motor and non-motor); their sample size was limited; the accuracy of detecting PD was low; it required special hardware, sensors and sophisticated techniques for acquiring the data like the speech and movement data which makes their implementation costly and difficult; and/or they used expensive methods involving SPECT scanning. In our previous work [26] , we used a combination of non-motor features of olfactory loss and Rapid Eye Movement sleep Behavior Disorder, along with other relevant biomarkers of Cerebrospinal fluid (CSF) measurements and SPECT imaging markers to develop predictive models for detecting early PD.
Previous studies based on Patient Questionnaires (PQ) for PD have shown that the questionnaire features capture significant amount of information that helps in diagnosis [27] [28] [29] [30] . The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) [31] is a widely used rating scale evaluating both motor as well as non-motor aspects of PD, and estimating its severity and progression. MDS-UPDRS consists of 4 parts and among which a portion of Part I (Parts IB, hereafter) and Part II, containing a total of 20 questions, is in the form of a patient questionnaire. Part IB assesses the non-motor aspects of daily living and Part II assess the motor aspects of daily living. Studies [31] [32] [33] [34] have validated these parts and have observed that they provide a relevant estimate of PD symptoms. The Hoehn and Yahr (HY) scale is another widely used scale for assessing PD stage [35] . This scale provides an overall assessment of severity through staging. The progression of PD usually starts from unilateral We have used the data from healthy normals and PD subjects who are in their early stages in our analysis. Developing predictive models that can perform classification or compute the likelihood of PD using patient questionnaire features is the approach that we carry out in this paper. There have been attempts to relate UPDRS (previous version of MDS-UPDRS) and the severity of PD through estimating the HY stage [37] [38] [39] . Scanlon et al. [37, 38] propose formulas to obtain HY stages from UPDRS Part III scores. Tsanas et al. [39] optimize this formula by refining its parameters using genetic algorithm (GA). However, these studies do not carry out predictive modelling and their formula was based on intuitive rules, and furthermore, Part III of MDS-UPDRS which they used requires an expert PD clinician for rating.
There are multiple advantages of using PQ features from MDS-UPDRS: a) it is simple to understand [31] , they are easy to administer and can be administered even by primary physicians who are not PD experts , it is cheap and does not involve any invasive procedures; b) they have been extensively tested and validated in patient groups, and are observed to reflect an effective and relevant estimate of broad spectrum of symptoms in PD [31] [32] [33] [34] ; c) subjects can fill the questionnaire themselves. Studies based on PQ parts of UPDRS [40] (MDS-UPDRS is the updated version of UPDRS) show that PD patient self-assessment and caregiver evaluation of the patient's disability showed close concordance with the neurologist's ratings, and that they are a reliable and valid outcome measure [41, 42] ; d) it assesses both non-motor (Part-IB) and motor (Part-II) features of PD [31] .
In this paper, we use the PQ parts (Parts IB and II) of MDS-UPDRS [31] ) along with demographic information to classify PD patients from healthy normal using logistic regression, random forests, boosted trees and support vector machine (SVM).
Materials and Methods

Dataset details
The data used for the study was from the Parkinson's Progression Markers Initiative (PPMI) that recruits early-untreated PD patients along with age-and gender-matched healthy normal subjects, to identify progression biomarkers in PD.
We have used the PQ portion of the MDS-UPDRS for the analysis. The complete MDS-UPDRS is freely available online at https://www.movementdisorders.org/MDS-Files1/PDFs/RatingScales/MDS-UPDRS_English_FINAL.pdf. And the research article [31] PPMI is a longitudinal study where both PD and healthy subjects undergo a comprehensive longitudinal schedule of assessments [43] . Evaluations occur at screening/baseline and at 3 month intervals during the first year of participation and then every 6 months thereafter for the next four years and it is followed by yearly assessment thereafter. The dataset contained observations for close to 7 years (July 2010 to April 2017). Average number of follow up visits for healthy normal is 5.06 and for PD is 9.92. The dataset consisted of a total of 5704 observations with 1002 samples from 198 healthy normal subjects, and 4702 samples from 474 early PD [44] (Hoehn and Yahr stage 1 or 2 with mean as 1.62) patients. The PQ was filled either by the patient / caregiver / patient and caregiver combined. Table 1 shows the distribution for each category. It is observed that around 99% of the healthy normal subjects and 95% early PD subjects put the ratings themselves. 
Data Partitioning
As PPMI is a longitudinal study where subjects are followed up, measurements are taken at different time points for each subject. In this study, along with record-wise cross-validation, we also carry out subject-wise cross-validation. In subject-wise cross-validation, the data is partitioned in a 10-fold cross-validation set up such that for each fold about 90% subjects, i.e.
data from 605 subjects (178 Normal + 427 Early PD) were used for training and rest about 10% subjects, i.e., data from 67 subjects (20 Normal + 47 Early PD) were used for testing, and this cross-validation process is repeated 100 times. In record-wise cross-validation, the data is partitioned in a 10-fold cross-validation set up such that for each fold 90% of the whole data, i.e., 5134 observations were used for training and rest 10%, i.e., 570 observations were used for testing, and this cross-validation process is repeated 100 times The partitioning of the dataset into training and testing sets is carried out in a stratified manner, i.e., in such a way that both sets are mutually exclusive and have roughly the same class proportions as in the set of class labels.
The average measure from the 100 cross-validation runs is taken to get an unbiased estimate of performance measures used which are accuracy, sensitivity, specificity and area under the ROC curve (AUC). 
Feature selection techniques used
Feature selection is a necessary step before predictive modelling when there is redundancy between the features. It is also necessary as decreased set of features reduces the size of the problem which makes the training time lesser, and there is lesser chance of overfitting. To carry out feature selection, we use the techniques as mentioned below:
Wilcoxon rank sum test
It is a filter based method where the selection of features is carried out based on (univariate) statistical tests. In this study, we use the Wilcoxon rank sum test for analyzing the significance of features. The Wilcoxon rank sum test is a nonparametric test for two populations to test for the equality of the population medians [45] . We use this test, instead of the t-test as most of the features do not show a normal distribution. For illustration, the histograms of the first four features are as shown below in Figure 4 . Fig. 4 . Histograms of the first four features. We can clearly observe that the histograms are highly skewed. This is because the PD subjects in the study were all in their early stages where the symptoms were less severe.
LASSO based feature selection
Least Absolute Shrinkage and Selection Operator (LASSO) is a regularization technique which applies a shrinking process where it penalizes the coefficients of the regression variables shrinking some of them to zero [46] . During this process, the variables that still have a non-zero coefficient are selected for subsequent prediction modelling.
PCA
PCA is a dimensionality reduction technique used to decompose a multivariate dataset to a set of orthogonal components. It converts the dataset of possibly correlated variables into a set of values of linearly uncorrelated variables called principal components. These components are obtained from the eigenvectors of the covariance matrix, and give directions in which the data have maximal variance [47] . In that way, the first principal component has the largest possible variance. Features are selected such that the total percentage of variance explained by selected components is not less than 99%.
Predictive modelling for distinguishing early PD from healthy normal
The input data can be represented as = [ 1 , 2 , … , ] ; = 1, … , ; k is number of features, k = 22, and n is number of observations, n=5704; and the output class as ∈ {0, 1} where 0 and 1 represent normal and early PD, respectively. The goal of the predictive model is to compute ( | ) which is the output class (or probability of PD) for an observation .
For classification, we use conventional techniques such as logistic regression [47] which is among the most popular techniques used in biomedical, as well as more recent techniques such as random forests [48, 49] , boosted trees [50] and SVM [51] that are becoming very popular in biomedicine [49, 52] . We use statistics toolbox in MATLAB to carry out classification using logistic regression, random forests and boosted trees, and LIBSVM [53] library for SVM modelling. More detailed description of these techniques is given in the Supplementary file.
Variable importance
Along with classification, Random forests technique was also used to evaluate feature importance [48] . During bagging (which is selecting samples with replacement) process as used in Random forests, it leaves out about 37% of the examples for each tree. It means that each tree is trained using only about 63% of the data on average. These left out examples are called out-of bag (OOB) samples. The first step in computing the variable importance is to fit a Random forests model to the data. Compute the OOB error which is the misclassification rate for OOB observations in the data. After this, to estimate the importance of the j th feature, the values of the j th feature are randomly permuted (shuffled) in the training data and the OOB error is again computed on this perturbed data set. The importance score for the feature is computed by averaging the difference in OOB error before and after the permutation. The score is normalized by the standard deviation of these differences. Features with higher scores are ranked higher.
Results
Feature Selection
For the analysis, a 10-fold nested cross-validation based approach was carried out where the feature selection and parameter tuning happens in the inner fold and evaluation happens in an independent set (or fold).
Features Selected from Wilcoxon rank sum test
The features are statistically tested using two-sided Wilcoxon rank sum test and 21of them were observed to be statistically significant in all folds (p-value << 0.05). Age was statistically insignificant as both the groups (Healthy normal and Early PD) were age matched. Table 2 below shows the results of this statistical testing. All features, except age, were included in the subsequent prediction modelling. 
Features selected from LASSO technique
A 10-fold cross-validated lasso regularization of a logistic regression model is created for feature selection. The features having non-zero coefficients were selected and the rest were discarded in each fold of the nested cross-validation.
Features selected from PCA
PCA decorrelates the features and finds a new representation from the existing features. Here, we have selected those many principal components which retain 99% of the total variance. Figure 5 as shown below visualizes the transformed representation using the first three features. The plot shows the largest variability along the first principal component axis. The second principal component axis has the second largest variability, which is significantly smaller than the variability along the first principal component axis. Similarly for the third principal component axis. Fig. 5 . Visualization of the first three transformed features using PCA
Hyperparameter selection
Hyper parameter optimization for the methods of Boosted Trees, Random Forest and SVM were carried out using Bayesian optimization [54] in a nested cross-validation framework. The
Bayesian optimization algorithm attempts to minimize a scalar objective function f(x) for x in a bounded domain. For Boosted trees and SVM, the optimization function was 10-fold cross validation error and for Random forest, the function was the out-of-bag error.
Performance measures of the classifiers used
The performance metrics obtained for the classifiers used is shown in Table 3 below. It is observed that all the classifiers performed with high accuracy and high AUC. To statistically compare the performances from the classifiers, multiple comparison tests were carried out [26, 55] . In this procedure, one-way ANOVA followed by post hoc tests using Tukey-Kramer method were carried out for multiple comparison analysis to determine which pairs of means are significant and which are not. The figure below (Fig. 6) shows the plots obtained from these tests. In each plot, the mean of the classifier performance measure is represented by a circle symbol and an interval (95% confidence interval) around the symbol. Two means are significantly different if their intervals are disjoint, and are not significantly different if their intervals overlap. In the plots below, solid blue line represent the best performing methods and solid red line represent the groups whose means were significantly different from the best performing method. From these plots, we observe that SVMs were always gave comparable performance with the best performing methods. Wilcoxon rank sum test, LASSO based, and PCA based feature selection.
Comparison of machine learning models with the patient questionnaire scores
In clinical setting, the total score is an important factor considered. However, there is no threshold that is reported that can be used to distinguish between PD and healthy normal. To compare the performance of questionnaire alone with the machine learning approaches, we have taken the total score of the questionnaire and then plotted the AUCs. The below figure (Fig. 7) shows the AUCs for different approaches, and we can clearly observe that the machine learning approaches are performing much better here. 
Logistic regression model
The performance metrics obtained for logistic regression are shown in Table 3 
Discussion
Note on final models
The main focus of the study was to develop predictive models using patient questionnaire in classifying early PD from healthy normal. Different machine learning techniques were used and compared. All the classifiers performed well and produced comparable performance. Table 3 shows the performance measures obtained for classifiers for subject-wise and record-wise case with feature selection using Wilcoxon rank sum test, LASSO and PCA.
Among all the techniques used, logistic regression is capable of giving the likelihood of PD in terms of a probability. The logistic model using full data is given in Section 3.2. In similar fashion, the Boosted trees, Random forests and SVM models can be built using the full data. The logistic model showed a statistically significant goodness-of-fit measure as indicated by the R 2 value. This indicates a good fit to the data, and hence is useful as a predictive model. These prediction models show the potential to aid in the initial evaluation of a subject, which can be followed with clinical evaluation by an PD expert and/or SPECT imaging that has the potential to enhance and validate the diagnostic decision significantly, and thereby can be used a secondary evaluation measure (as it is very expensive). Table 4 shows a comparison of our study with other related works in developing machine learning based prediction models for PD detection. The contributions (advantages) of this study can be summarised as follows: a) We improve the works of [32] [33] [34] by providing a different perspective of using PQ to develop prediction models for the early PD vs. normal classification.
b) It does not need any special hardware (like in the speech recording or motion recording works) for data acquisition. Instead, it uses a cheap and simple patient questionnaire that can be used even by primary physicians who are not experts in PD.
c) The sample size used is largest as compared to related works in PD detection [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [21] [22] [23] .
d) The classification accuracy is comparable with related works in PD detection [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [21] [22] [23] . 
A note on misclassified instances
To illustrate the misclassified instances, the figures 9 and 10 as given below show the stacked bar charts for the misclassified instances from the Random forests classifier for the subject-wise and record-wise cases, respectively. These plots show the collective misclassified instances from the 100 runs of 10-fold cross-validations. We can see that the pattern for misclassified healthy normals is way different from the severity pattern that we observe in Figure 1 . We can clearly observe from the plots that those healthy normals who showed a severity pattern close to that of early PD were misclassified as early PD. And for the early PD case, as the training data involved few healthy normal instances which showed a severity pattern close to that of early PD, the classifier learned to these instances and misclassified few early PD instances as healthy normal.
Similar patterns were observed with other classifiers as well. These misclassifications can be reduced by incorporating other features such as inputs from PD experts and/or neuroimaging can increase the performance to a great extent. Generally the clinician looks at the total score of the questionnaire for evaluating a subject. The total of the questionnaire features gave a higher correlation of 0.54 with the HY stage.
The correlation of the sum of MDS-UPDRS part III with HY was observed to be 0.76 which is higher as compared to the correlation for the sum of the questionnaire. Incorporation of part III could enhance the performance of the models which is a further extension of the present study.
Note on screening instrument for PD
In the present paper, the prediction models developed could aid a primary physician, who is not a PD expert, to detect possible case of PD and subsequently he/she may refer the subject to an PD expert for confirmatory neurological examination and other expensive tests such as the SPECT scan which provides a specificity as high as 100% [56] . Screening for PD is a clinical need as there exist no approaches as of now that can be used as a screening tool. Developing a screening tool possibly from tool like a patient questionnaire for PD is a long term goal and the presented approaches are like first steps towards that long term goal. The requirements for any screening instrument that can be used for population-wide studies are that it must be sensitive, specific, inexpensive, and non-invasive. An effective screening instrument/tool can serve the following:
i. To identify undiagnosed and preclinical stage PD to initiate early management and therapeutic intervention.
ii. To carry out prevalence studies for evaluating the burden of PD, especially in developing countries where access to health care is limited, and thereby helping policy makers to estimate health care costs and allocate resources more efficiently.
iii. It can aid in clinical trial studies such as the PPMI for recruiting new subjects.
Limitations and future work
A limitation of this study is that the binary classification (early PD/healthy normal) does not provide a differential diagnosis (i.e., diagnosis of PD from other forms of Parkinsonism which
show PD-like symptoms such as multiple system atrophy, progressive supra-nuclear palsy and corticobasal degeneration), but it is a promising first step toward that long-term goal.
Incorporation of data for these neurodisorders is another possible extension of the present study.
Furthermore, sensitivity from a PQ would be much lower as compared to SPECT scans. But our study mainly focused on PQ due to its ease of use and cost-effectiveness. Studies have established that PD patient self-assessment or caregiver evaluation of a patient's disability (based on patient questionnaire) show very close concordance with the neurologist's ratings, and that they are reliable and valid outcome measures [41, 42] . However, a comparison with neurologist's rating, which we have not carried out in this study, can further add value to the work. It is to be noted that a study by Martinez-Martin et al. [41] observed that a doctor's rating from a questionand-answer session may bias patient's answers, or underestimate its severity. A self-administered patient questionnaire does not suffer from these biases, and as such, may be a better tool to collect such data.
This proposed approach is an alternative way of joining the items of an existing questionnaire through machine learning. However, it is to be noted that the PPMI group in their research article had acknowledged that the study recruitment is a major challenge for the PPMI due to the difficulty in identifying early-untreated PD subjects. The group, working closely with the Michael J Fox Foundation, had developed a template which they use for recruiting new subjects.
The patients have been clinically diagnosed as PD and they form the ground truth or target variable for our study, which enables us to develop predictive models using it. And these models could potentially be used as a clinical aid as well for identifying subjects for clinical trials.
Application of this approach for detecting prodromal phase is interesting which is a worthy candidate for future work.
Furthermore, deep learning is an area of machine learning that is increasingly being used in biomedicine. It involves representation-learning methods composing of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in many supervised classification tasks [57] . These techniques could be applied for generating more complex insights, but for that a substantial amount of data is necessary. Along with this, including sensor data, when it becomes available in the PPMI database, to the problem could further add value to the work.
A note on the lack of correlations with subjective-objective data
The items in the questionnaire data which is of subjective type had a weak to moderate correlations (0.10 -0.38) with the Hoehn and Yahr (HY) stage as we can observe from Figure   11 . Although, these correlations were lower, the correlation for the sum of these 20 items came around 0.54 which is a reasonably stronger correlation as compared to individual features.
The SBR data which is of objective type had moderate correlations (0.45 -0.56) with the HY stage. The total SBRs also had moderate correlations, but slightly higher, with the HY stage. A possible reason for the lower correlations could be that we had used only 3 categories for the HY which are normal, stage 0 and stage 1, rather than using the full spectrum of HY. Another reason could that the progression of the disease is a non-linear process and varies from person to person.
However, a further study on the lack of these correlations is a promising future work.
Few other recommendations
Literature survey shows that there have been many studies using a variety of data such as imaging data, smell data, movement data, speech data, etc, but only few works focused on developing predictive models using patient questionnaire data. From our study, we demonstrate that effective machine learning models can be developed using the PQ data. In our analysis, we had used the PQ portion of the MDS-UPDRS. This work could be extended by including other patient questionnaires (or any other data) for Parkinson's disease which might improve the performance of the models. Along with that neural network techniques could be used which are capable of learning refined representations from the data, and could possibly perform dimensionality reduction along with performance improvement.
Conclusion
Computer-aided detection or classification has the potential to reduce inevitable fallibilities and inherent diagnostic variabilities in healthcare, provide guidance and speed up decision-making.
The seemingly vast and promising opportunities that machine learning will bring to healthcare will also advance precision medicine and disease management at the level of individual patients.
Early detection of PD is an important step to understand the causes, develop better treatments and carry out effective early management of the disease. The importance of diagnostic tools stems from the fact that they can aid in the early detection of PD. In this study, we use the patient questionnaire parts of the widely used MDS-UPDRS to classify early PD cases from healthy normal, to develop prediction models using a variety of classifiers. We observe that these predictive models performed with high accuracy and AUC in distinguishing early PD cases from normal. We infer from the study that such diagnostic models might have the potential to be used as an aid in clinical setting by primary physicians when PD expert are not available, for detecting PD and also for identifying subjects for clinical trials.
